文献速递物质与行为成瘾

美国人群不同性身份谱系中的物质使用模式

Substance Use Patterns Across the Sexual Identity Spectrum Among U.S. Individuals.
PubMed 文献 · Am J Psychiatry · 2026-02-18

基于2023年美国药物使用与健康调查中12岁及以上人群(N=52,525),研究比较了异性恋、男/女同性恋、双性恋、使用其他术语描述性身份者及性身份不确定者过去一年多种物质使用情况。结果显示所有非异性恋身份群体物质使用均高于异性恋者,双性恋和男/女同性恋者在多数物质上比值升高,使用其他术语者和不确定者在吸入剂、致幻剂、大麻及处方镇静剂/安定剂滥用上比值升高。

要点

  • 所有非异性恋身份群体过去一年物质使用均高于异性恋者。
  • 双性恋和男/女同性恋者在多数物质上比值升高,尤其吸入剂、致幻剂和大麻。
  • 使用其他术语者和性身份不确定者在吸入剂、致幻剂、大麻及处方镇静剂/安定剂滥用上比值升高。

核心结论

  • 非异性恋身份群体物质使用普遍高于异性恋者,使用其他术语和性身份不确定群体也呈现独特升高模式。

研究设计与样本

  • 基于2023年美国药物使用与健康调查中12岁及以上人群(N=52,525)的横断面分析。

主要发现

  • 所有非异性恋身份群体过去一年物质使用均高于异性恋者。
  • 双性恋和男/女同性恋者在多数物质上比值升高,尤其吸入剂、致幻剂和大麻。
  • 使用其他术语者和性身份不确定者在吸入剂、致幻剂、大麻及处方镇静剂/安定剂滥用上比值升高,使用其他术语者还在处方兴奋剂滥用上比值升高。
  • 按性别分层分析中,男性和女性均在多种物质上比值升高,女性升高的物质种类通常更多,部分男性估计因样本量小被抑制。

临床怎么用

  • 筛查和预防策略应覆盖双性恋、男/女同性恋之外的使用其他术语描述性身份者和性身份不确定者。

局限性

  • 按性别分层分析中部分男性估计因样本量小被抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to examine substance use patterns across the sexual identity spectrum, particularly among individuals who describe their sexual identity using different terms or express uncertainty about their orientation-groups that remain poorly understood beyond lesbian, gay, or bisexual (LGB) categories. METHODS: Using data from the 2023 National Survey on Drug Use and Health among individuals ≥12 years of age (N=52,525), the authors examined past-year substance use across five sexual identity groups: heterosexual, gay/lesbian, bisexual, those using a different term to describe their sexual identity, and those unsure of their identity. Associations were examined between sexual identity (overall and disaggregated by sex using sex-specific heterosexual reference groups) and past-year use of cannabis, hallucinogens, cocaine, inhalants, methamphetamine, and misuse of prescription opioids, tranquilizers/sedatives, and stimulants. RESULTS: Substance use was higher across all other sexual identity groups compared with heterosexual individuals. Bisexual and gay/lesbian individuals showed elevated odds across most substances examined, particularly inhalants, hallucinogens, and cannabis. Both individuals using different terms and those unsure of their sexual identity showed elevated odds for inhalants, hallucinogens, cannabis, and prescription tranquilizer/sedative misuse, with those using different terms additionally showing elevated odds for prescription stimulant misuse. In sex-disaggregated analyses, both males and females showed elevated odds across multiple substances, with females generally showing elevations across a greater number of substances, although some estimates for males were suppressed due to small sample sizes. CONCLUSIONS: These findings extend our understanding of substance use beyond LGB categories, revealing nuanced patterns among emerging identity groups, underscoring the importance of targeted screening and prevention strategies.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Yang KH, Mueller LA, Han BH, et al. Substance Use Patterns Across the Sexual Identity Spectrum Among U.S. Individuals. Am J Psychiatry. 2026. PMID: 41703691. doi:10.1176/appi.ajp.20250206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。